EMAIL THIS PAGE TO A FRIEND

PloS one

Cell cycle-dependent phosphorylation of Theileria annulata schizont surface proteins.


PMID 25077614

Abstract

The invasion of Theileria sporozoites into bovine leukocytes is rapidly followed by the destruction of the surrounding host cell membrane, allowing the parasite to establish its niche within the host cell cytoplasm. Theileria infection induces host cell transformation, characterised by increased host cell proliferation and invasiveness, and the activation of anti-apoptotic genes. This process is strictly dependent on the presence of a viable parasite. Several host cell kinases, including PI3-K, JNK, CK2 and Src-family kinases, are constitutively activated in Theileria-infected cells and contribute to the transformed phenotype. Although a number of host cell molecules, including IkB kinase and polo-like kinase 1 (Plk1), are recruited to the schizont surface, very little is known about the schizont molecules involved in host-parasite interactions. In this study we used immunofluorescence to detect phosphorylated threonine (p-Thr), serine (p-Ser) and threonine-proline (p-Thr-Pro) epitopes on the schizont during host cell cycle progression, revealing extensive schizont phosphorylation during host cell interphase. Furthermore, we established a quick protocol to isolate schizonts from infected macrophages following synchronisation in S-phase or mitosis, and used mass spectrometry to detect phosphorylated schizont proteins. In total, 65 phosphorylated Theileria proteins were detected, 15 of which are potentially secreted or expressed on the surface of the schizont and thus may be targets for host cell kinases. In particular, we describe the cell cycle-dependent phosphorylation of two T. annulata surface proteins, TaSP and p104, both of which are highly phosphorylated during host cell S-phase. TaSP and p104 are involved in mediating interactions between the parasite and the host cell cytoskeleton, which is crucial for the persistence of the parasite within the dividing host cell and the maintenance of the transformed state.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1406503
Anti-T antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1412153
ANTI-T antibody produced in mouse, clone 5C6, purified immunoglobulin, buffered aqueous solution
SAB1412159
ANTI-T antibody produced in mouse, clone 5C10, purified immunoglobulin, buffered aqueous solution
SAB1412193
ANTI-T antibody produced in mouse, clone 5C8, purified immunoglobulin, buffered aqueous solution
SAB1412313
ANTI-T antibody produced in mouse, clone 5E11, purified immunoglobulin, buffered aqueous solution
SAB1412314
ANTI-T antibody produced in mouse, clone 6D3, purified immunoglobulin, buffered aqueous solution
SAB1412315
ANTI-T antibody produced in mouse, clone 5E12, purified immunoglobulin, buffered aqueous solution
SAB1412316
ANTI-T antibody produced in mouse, clone 2A12, purified immunoglobulin, buffered aqueous solution
SAB1412317
ANTI-T antibody produced in mouse, clone 1H1, purified immunoglobulin, buffered aqueous solution
SAB1404434
Monoclonal Anti-T antibody produced in mouse, clone 5H8, purified immunoglobulin, buffered aqueous solution
677469
Titanium(IV) oxide, contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
O2Ti
718467
Titanium(IV) oxide, nanopowder, 21 nm primary particle size (TEM), ≥99.5% trace metals basis
O2Ti
774510
Titanium(IV) oxide, nanowires, diam. × L ~100 nm × 10 μm
O2Ti
774529
Titanium(IV) oxide, nanowires, diam. × L ~10 nm × 10 μm
O2Ti
637254
Titanium(IV) oxide, anatase, nanopowder, <25 nm particle size, 99.7% trace metals basis
O2Ti
232033
Titanium(IV) oxide, anatase, powder, 99.8% trace metals basis
O2Ti
248576
Titanium(IV) oxide, anatase, powder, −325 mesh, ≥99% trace metals basis
O2Ti
634662
Titanium(IV) oxide, mixture of rutile and anatase, nanopowder, <100 nm particle size (BET), 99.5% trace metals basis
O2Ti
700355
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticle, <250 nm particle size (DLS), paste, 53-57 wt. % in diethylene glycol monobutyl ether/ethylene glycol, 99.9% trace metals basis
O2Ti
700347
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticles, <150 nm particle size (volume distribution, DLS), dispersion, 40 wt. % in H2O, 99.5% trace metals basis
O2Ti
700339
Titanium(IV) oxide, mixture of rutile and anatase, nanoparticles, <100 nm particle size, dispersion, 48-52 wt. % in xylene, 99.9% trace metals basis
O2Ti
204730
Titanium(IV) oxide, rutile, 99.995% trace metals basis
O2Ti
204757
Titanium(IV) oxide, rutile, ≥99.98% trace metals basis
O2Ti
635057
Titanium(IV) oxide, rutile, <001>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
635049
Titanium(IV) oxide, rutile, <100>, (single crystal substrate), ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
635065
Titanium(IV) oxide, rutile, <110>, single crystal substrate, ≥99.9% trace metals basis, L × W × thickness 10 mm × 10 mm × 0.5 mm
O2Ti
637262
Titanium(IV) oxide, rutile, nanopowder, <100 nm particle size, 99.5% trace metals basis
O2Ti
224227
Titanium(IV) oxide, rutile, powder, <5 μm, ≥99.9% trace metals basis
O2Ti
WH0006862M2
Monoclonal Anti-T antibody produced in mouse, clone 5C5, purified immunoglobulin, buffered aqueous solution